Close
Close
Treatment Database
Cytarabine:daunorubicin liposome injection
Trade Name Vyxeos
Orphan Indication Acute myeloid leukemia
USA Market Approval 03-08-2017
USA Designation Date 22-08-2008
Sponsor Celator Pharmaceuticals, Inc.
200 Princeton South Corporate Center, Suite 180
Ewing, New Jersey, 08628
More about Acute myeloid leukemia
Free Newsletter
Treatment News
Related Videos